Ticker Symbol: BGAIF
BioGaia AG - Class B
Exchange: US OTC
Country:
SE
Currency:
USD
Asset
Type: Common Stock
CIK:0001572957
Company Profile
BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment sells drops, oral rehydration solutions, digestive health tablets, and also royalties pertaining to pediatric products. The Adult Health segment include gut health tablets, oral health products, and offers cultures as an ingredient in a licensee's dairy product. The Other segment consists royalties from the development projects, and revenue from packaging solutions. The company was founded by Jan Annwall and Peter Rothschild in 1990 and is headquartered in Stockholm, Sweden.
Sector: Health Technology
Industry: Pharmaceuticals: Major
Standard Industrial Classification Code (SIC code): 2834
Address: Kungsbroplan 3
Website: http://www.biogaia.com
CEO: Isabelle Valerie G. Ducellier
Tags:
- Biotechnology
- Health Technology
- Pharmaceuticals: Major
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: $10.03 - $10.03
Beta: -
52wk. High: $63.69
52wk. Low: $10.03
Ytd. Change -82.01%
50 Day Moving Average: $10.03
200 Day Moving Average: $45.51
Shares Outstanding: 19455794
Valuation
Market Cap: 19.5B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): $14.92
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: May 9, 2022